Cargando…
Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Lupus Nephritis by Using Mycophenolate Mofetil
An estimated 0.9% to 2.4% of patients with systemic lupus erythematosus (SLE) also have hemophagocytic lymphohistiocytosis (HLH). HLH associated with autoimmune diseases is often refractory to corticosteroid treatment; thus, additional immunosuppressive drugs, such as cyclosporine, cyclophosphamide,...
Autores principales: | Nawata, Takashi, Kubo, Makoto, Shiragami, Kosaku, Nakamura, Yukinori, Yano, Masafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618750/ https://www.ncbi.nlm.nih.gov/pubmed/29062579 http://dx.doi.org/10.1155/2017/4159727 |
Ejemplares similares
-
Treatment of Class IV Lupus Nephritis with Mycophenolate Mofetil Monotherapy
por: Nawata, Takashi, et al.
Publicado: (2018) -
Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008) -
Successful Treatment with Mycophenolate Mofetil and Tacrolimus in Juvenile Severe Lupus Nephritis
por: Kise, Tomoo, et al.
Publicado: (2015) -
Use of mycophenolate mofetil (MMF) in lupus nephritis (LN) in children
por: Indaco, R, et al.
Publicado: (2008) -
Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)